Keith Woods - Dec 7, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Keith Woods
Stock symbol
RCKT
Transactions as of
Dec 7, 2023
Transactions value $
$0
Form type
4
Date filed
12/12/2023, 08:51 PM
Previous filing
Dec 8, 2023
Next filing
Jun 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +20.5K $0.00 20.5K Dec 7, 2023 Common Stock 20.5K $26.30 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +12K $0.00 12K Dec 7, 2023 Common Stock 12K $26.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026.
F2 This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024.